Dynamic Healthcare M&A Database

Acquiring Party	Cardium Therapeutics, Inc.. (OTC: CDTP), a technology company focused on development, manufacture and sale of new and innovative therapeutic products for the interventional cardiology market.
Transferring Party	InnerCool Therapies, Inc., a developer of endovascular catheter systems to rapidly and controllably lower patient body temperature during surgery and intensive care.
Sector	Medical Devices
Date	March 9, 2005
Analysis Complements Cardium's biologic approach to the treatment of cardiovascular disease. Potential future applications of InnerCool's technology include endovascular cooling for cardiac arrest, acute ischemic stroke and myocardial infarction (heart attack). Cardium will issue 2.5 million common and will assume certain outstanding liabilities ($560,000) plus Deal costs and vacation accrual). Potential milestone payment of $5 million if InnerCool sales exceed $20 million.
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason.

Dynamic Healthcare M&A Database - 1Q05